Bank Of Hawaii Vertex Pharmaceuticals Inc Transaction History

Bank Of Hawaii

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$207.02 - $241.31 $456,893 - $532,571	-2,207 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$207.01 - $276.09 $235,991 - $314,742	-1,140 Reduced 34.06%	2,207 $522,000
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $239,544 - $284,004	937 Added 38.88%	3,347 $911,000
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $609,923 - $800,139	-2,705 Reduced 52.88%	2,410 $700,000
Q1 2020 May 13, 2020	SELL	$199.77 - $247.81 $452,479 - $561,289	-2,265 Reduced 30.69%	5,115 $1.22 Million
Q4 2019 Feb 12, 2020	SELL	$166.71 - $223.91 $174,545 - $234,433	-1,047 Reduced 12.42%	7,380 $1.62 Million
Q3 2019 Nov 15, 2019	BUY	$166.23 - $187.09 $16,290 - $18,334	98 Added 1.18%	8,427 $1.43 Million
Q2 2019 Aug 15, 2019	BUY	$164.61 - $190.37 $130,371 - $150,773	792 Added 10.51%	8,329 $1.53 Million
Q1 2019 May 10, 2019	BUY	$163.73 - $194.7 $548,004 - $651,660	3,347 Added 79.88%	7,537 $1.39 Million
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $99,501 - $125,897	-655 Reduced 13.52%	4,190 $694,000
Q3 2018 Nov 09, 2018	BUY	$167.73 - $192.74 $160,182 - $184,066	955 Added 24.55%	4,845 $934,000
Q2 2018 Aug 06, 2018	BUY	$145.72 - $169.96 $566,850 - $661,144	3,890 New	3,890 $661,000

1,722

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Bank Of Hawaii, based on Form 13F filings with the SEC.

Stay updated on Bank Of Hawaii with notifications on news.